BIOCAN NOVEL R
MANUFACTURER: Bioveta
PRODUCT CATEGORY: Vaccines
COMPOSITION:
Liquid fraction: Inactivated rabies virus, strain SAD Vnukovo-32 ≥ 2.0 IU***
Adjuvant: Aluminium hydroxide gel 1.8–2.2 mg
TARGET SPECIES ANIMAL: Dogs
INDICATIONS WITH SPECIFICATION FOR THE TARGET ANIMAL SPECIES:
Active immunization of dogs from 12 weeks of age to prevent mortality, clinical signs and infection caused by rabies virus. In case of need, dogs younger than 12 weeks can be vaccinated. In this case the vaccine can be administered from 6 weeks of age in two doses. The second dose should not be administered before 12 weeks of age and not earlier than 3 weeks after the first dose.
Onset of immunity: 2 weeks after a single vaccination from 12 weeks of age.
Duration of immunity: At least three years following the primary vaccination course.
PACKAGING: 10×1dose, 25×1dose.
